Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 10920-10929

  Chan, S R ^a   Chandran, B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; DOUBLE STRANDED DNA; GENE PRODUCT; MONOCLONAL ANTIBODY; PROTEIN PF 8; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA SEQUENCE; DOSE RESPONSE; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN HERPESVIRUS 8; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; VIRUS REPLICATION;

BINDING SITES; DNA; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; HERPESVIRUS 8, HUMAN; PHOSPHORYLATION; PRECIPITIN TESTS; VIRAL PROTEINS;

EID: 0034469501     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.10920-10929.2000     Document Type: Article

References (59)

1. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
2. Methods of analyzing processivity
3. Epidemiology of Kaposi's sarcoma
4. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody
5. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts
6. Identification, characterization, and sequence analysis of a cDNA encoding a phosphoprotein of human herpesvirus 6
7. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
8. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa
9. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
10. Functional analysis of EA-D of Epstein-Barr virus
11. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro
12. Herpes simplex virus 1 helicase-primase: A complex of three herpes-encoded gene products
13. Functional analysis of the herpes simplex virus UL42 protein
14. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma
15. Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
16. KSHV and Kaposi's sarcoma: The end of the beginning?
17. Cytomegalovirus-infected cells contain a DNA-binding protein
18. Use of antiherpes drugs and the risk of Kaposi's sarcoma: Data from the multicenter AIDS cohort study
19. Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template
20. The herpes simplex virus type 1 UL42 gene product: A subunit of DNA polymerase that functions to increase processivity
21. The herpes simplex virus type 1 DNA polymerase accessory protein, UL42, contains a functional protease-resistant domain
22. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma
23. Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype
24. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy
25. Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function
26. Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion
27. Cloning and functional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor
28. Sequence analysis and expression of the murine cytomegalovirus phosphoprotein pp50, a homolog of the human cytomegalovirus UL44 gene product
29. A temperature-sensitive mutation in a herpes simplex virus type 1 gene required for viral DNA synthesis maps to coordinate 0.609 through 0.614 in UL
30. r DNA-binding and virion trans-inducing proteins of herpes simplex virus type 1
31. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant
32. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus
33. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection
34. Two regions of the herpes simplex virus type 1 UL42 protein are required for its functional interaction with the viral DNA polymerase
35. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection
36. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma
37. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity?
38. Herpes simplex virus DNA replication: The UL9 gene encodes an origin binding protein
39. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase
40. Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1
41. Nonstructural proteins of herpes simplex virus. II. Major virus-specific DNA-binding protein
42. DNA-binding proteins of cells infected with herpes simplex virus type 1 and type 2
43. Identification of the herpes simplex virus DNA polymerase gene
44. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
45. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases
46. Biochemical characterization of two Epstein-Bart virus early antigen-associated phosphopolypeptides
47. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8)
48. Temperature-sensitive mutants of herpes simplex virus type 1: Isolation, complementation, and partial characterization
49. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8)
50. + patients and correlation with serological measurements
51. Deletions of the carboxy terminus of herpes simplex virus type 1 UL42 define a conserved amino-terminal functional domain
52. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system
53. On the processivity of polymerase
54. Herpes simplex virus processivity factor UL42 imparts increased DNA-binding specificity to the viral DNA polymerase and decreased dissociation from primer-template without reducing the elongation rate
55. Genetic analysis of temperature-sensitive mutants of HSV-1; the combined use of complementation and physical mapping for cistron assignment
56. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma
57. Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis
58. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase